Question 1

How many shares of EFTR does Carlyle Group Inc. own?

Accepted Answer

Carlyle Group Inc. previously held 0 shares of EFTR (eFFECTOR Therapeutics, Inc.) before exiting the position in 2024-Q3.

Question 2

What is Carlyle Group Inc.'s EFTR position worth?

Accepted Answer

Carlyle Group Inc.'s EFTR position was last reported at $0 in 2024-Q3 before the exit.

Question 3

Is Carlyle Group Inc. buying or selling EFTR?

Accepted Answer

In 2024-Q3, Carlyle Group Inc. exited their EFTR position entirely (-100.0% change in shares).

Question 4

When did Carlyle Group Inc. first buy EFTR?

Accepted Answer

Based on available 13F filings, Carlyle Group Inc. first reported a position in EFTR in 2023-Q1. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$0.04	0
2024-Q2	Unchanged	192,884	0.0%	$55,936	0.0%	$0.29	0
2024-Q1	Decreased	192,884	-96.0%	$2.7M	0.2%	$14.39	0
2023-Q4	Unchanged	4.8M	0.0%	$2.2M	0.1%	$11.69	0
2023-Q3	Unchanged	4.8M	0.0%	$2.9M	0.1%	$15.00	0
2023-Q2	Unchanged	4.8M	0.0%	$4M	0.1%	$18.99	0
2023-Q1	New	4.8M	-	$1.7M	0.1%	$8.74	37

EFTR7 quarters

EFTR
7 quarters